1. Suspected ShapeShift founder purchased approximately 50,700 ETH in the past 4 hours, with a transaction value of about $112 million;
2. The probability of "Kraken conducting an IPO in 2026" on Polymarket dropped to 29%, a 51% decline in 24 hours;
3. Abraxas Capital increased its short gold position again within 20 minutes, with a position size of approximately $18.8 million;
4. DWF Labs partner denied the "bearish on altcoins" remarks, stating the related reports are inaccurate;
5. A whale purchased approximately 4,583 ETH in the past 13 hours, accumulating about 10,800 ETH in the past two weeks.
6. Sky co-founder shorted the S&P 500 with 20x leverage while increasing a long Brent crude oil position with 7x leverage;
7. Hong Kong stock OpenClaw concept stocks corrected, with MINIMAX down over 5% and Zhipu down over 4%;
8. The European Union confirmed that US social media platform X has paid a €120 million fine.
Svmuu Noon News
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
5
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
9
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
10
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
Markets Today
Recommended Reading








